AIFM2 and neoplasm: In non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and pancreatic ductal adenocarcinoma (PDAC), FSP1 is expressed at higher levels in KRAS mutant tumor cells compared to normal cells [25].